O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.19%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.79B
AUM Growth
+$8.79B
(+13%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
37.24%
Holding
144
New
16
Increased
26
Reduced
29
Closed
10
Top Buys
| 1 |
Centene
CNC
|
$118M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
| 3 |
Merck
MRK
|
$69.9M |
| 4 |
AET
Aetna Inc
AET
|
$64.6M |
| 5 |
Viatris
VTRS
|
$50.7M |
Top Sells
| 1 |
Amgen
AMGN
|
$147M |
| 2 |
Neurocrine Biosciences
NBIX
|
$73.1M |
| 3 |
Intuitive Surgical
ISRG
|
$72.9M |
| 4 |
AGN
Allergan plc
AGN
|
$69.8M |
| 5 |
AbbVie
ABBV
|
$55.1M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Financials | 2.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
126
DELISTED
Amedisys
AMED
| – | – | -71,500 | Closed | -$3.05M |
|
127
Molina Healthcare
MOH
$9.8B
| – | – | -496,200 | Closed | -$26.9M |
|
128
PTC Therapeutics
PTCT
$3.92B
| – | – | -204,400 | Closed | -$2.23M |
|
129
Ultragenyx Pharmaceutical
RARE
$2.89B
| – | – | -169,300 | Closed | -$11.9M |
|
130
Rocket Pharmaceuticals
RCKT
$354M
| – | – | -1,849,300 | Closed | -$11.3M |
|
131
Sangamo Therapeutics
SGMO
$157M
| – | – | -707,400 | Closed | -$2.16M |
|
|
PTLA
132
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – | -551,500 | Closed | -$12.4M |
|
|
FWP
133
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| – | – | -798,000 | Closed | -$12M |
|
|
ARLZ
134
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| – | – | -68,143 | Closed | -$301K |
|